Publication: 2762

Publication: 2762

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Ann Oncol vol 28 (11) 2806-12

Year:: 2017
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 7

Parents:: 979 2123 2704
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:: Correl Sci NOS

Pharmas:: Annals of Oncology
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA007968, U10CA077597, U10CA180833, U10CA180850, U10CA180838

Corr. Author:
Authors:: P Martin S -H Jung B Pitcher N L Bartlett K A Blum T Shea E D Hsi J Ruan S E Smith J P Leonard B D Cheson

Networks:: CAPITAL, IL017, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, NY018

Study: CALGB-50803
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: